Marko J. Kallio

3.6k total citations
57 papers, 2.9k citations indexed

About

Marko J. Kallio is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Marko J. Kallio has authored 57 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 36 papers in Cell Biology and 9 papers in Oncology. Recurrent topics in Marko J. Kallio's work include Microtubule and mitosis dynamics (34 papers), Photosynthetic Processes and Mechanisms (13 papers) and DNA Repair Mechanisms (11 papers). Marko J. Kallio is often cited by papers focused on Microtubule and mitosis dynamics (34 papers), Photosynthetic Processes and Mechanisms (13 papers) and DNA Repair Mechanisms (11 papers). Marko J. Kallio collaborates with scholars based in Finland, United States and Germany. Marko J. Kallio's co-authors include Gary J. Gorbsky, P. Todd Stukenberg, Mark L. McCleland, John R. Daum, Jaana Lähdetie, Daniel J. Burke, Jasminder Weinstein, Lea Sistonen, John Eriksson and Asta Varis and has published in prestigious journals such as Journal of Biological Chemistry, Genes & Development and The Journal of Cell Biology.

In The Last Decade

Marko J. Kallio

56 papers receiving 2.9k citations

Peers

Marko J. Kallio
Helfrid Hochegger United Kingdom
Robert N. Booher United States
Nick Rhind United States
Nancy C. Walworth United States
Clare H. McGowan United States
Karen Lundgren United States
Marko J. Kallio
Citations per year, relative to Marko J. Kallio Marko J. Kallio (= 1×) peers Daniel Fisher

Countries citing papers authored by Marko J. Kallio

Since Specialization
Citations

This map shows the geographic impact of Marko J. Kallio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko J. Kallio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko J. Kallio more than expected).

Fields of papers citing papers by Marko J. Kallio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marko J. Kallio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko J. Kallio. The network helps show where Marko J. Kallio may publish in the future.

Co-authorship network of co-authors of Marko J. Kallio

This figure shows the co-authorship network connecting the top 25 collaborators of Marko J. Kallio. A scholar is included among the top collaborators of Marko J. Kallio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marko J. Kallio. Marko J. Kallio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kallio, Marko J., Viktoriia Starokozhko, Manja Burggraf, et al.. (2022). Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in Europe. Clinical Pharmacology & Therapeutics. 113(2). 349–359. 10 indexed citations
2.
Starokozhko, Viktoriia, Marko J. Kallio, Mark Goldammer, et al.. (2020). Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap. Drug Discovery Today. 26(2). 283–288. 21 indexed citations
3.
Straume, Anne Hege, et al.. (2018). MYC-Induced miR-203b-3p and miR-203a-3p Control Bcl-xL Expression and Paclitaxel Sensitivity in Tumor Cells. Translational Oncology. 12(1). 170–179. 25 indexed citations
4.
Rickardson, Linda, et al.. (2017). Evaluation of the antitumor activity of NOV202, a novel microtubule targeting and vascular disrupting agent. Drug Design Development and Therapy. Volume 11. 1335–1351. 5 indexed citations
5.
Mäki-Jouppila, Jenni H., et al.. (2015). MicroRNA let‐7b regulates genomic balance by targeting Aurora B kinase. Molecular Oncology. 9(6). 1056–1070. 19 indexed citations
6.
Mäki-Jouppila, Jenni H., Pasi Halonen, Arne Lindqvist, et al.. (2014). Centmitor-1, a Novel Acridinyl-Acetohydrazide, Possesses Similar Molecular Interaction Field and Antimitotic Cellular Phenotype as Rigosertib, ON 01910.Na. Molecular Cancer Therapeutics. 13(5). 1054–1066. 5 indexed citations
7.
Farshchian, Mehdi, Johanna Tuomela, Jouko Sandholm, et al.. (2014). Inhibition of c-Abl Kinase Activity Renders Cancer Cells Highly Sensitive to Mitoxantrone. PLoS ONE. 9(8). e105526–e105526. 9 indexed citations
8.
9.
Pouwels, Jeroen, et al.. (2011). The flavonoid eupatorin inactivates the mitotic checkpoint leading to polyploidy and apoptosis. Experimental Cell Research. 318(5). 578–592. 21 indexed citations
10.
Holmström, Tim H., et al.. (2009). Ectopic expression of plasma membrane targeted subunits of the Ndc80‐complex as a tool to study kinetochore biochemistry. Molecular Oncology. 3(3). 262–268. 2 indexed citations
11.
Pouwels, Jeroen, Asta Varis, Pasi Halonen, et al.. (2009). Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint. Carcinogenesis. 30(6). 1032–1040. 42 indexed citations
12.
Pellinen, Teijo, Saara Hämälistö, Antti Arjonen, et al.. (2008). Integrin Trafficking Regulated by Rab21 Is Necessary for Cytokinesis. Developmental Cell. 15(3). 371–385. 159 indexed citations
13.
Emanuele, Michael J., et al.. (2007). Multiple mechanisms of chromosome movement in vertebrate cells mediated through the Ndc80 complex and dynein/dynactin. Chromosoma. 117(2). 169–179. 60 indexed citations
14.
McCleland, Mark L., Marko J. Kallio, Gregory A. Barrett‐Wilt, et al.. (2004). The Vertebrate Ndc80 Complex Contains Spc24 and Spc25 Homologs, which Are Required to Establish and Maintain Kinetochore-Microtubule Attachment. Current Biology. 14(2). 131–137. 143 indexed citations
15.
McCleland, Mark L., Marko J. Kallio, John R. Daum, et al.. (2003). The highly conserved Ndc80 complex is required for kinetochore assembly, chromosome congression, and spindle checkpoint activity. Genes & Development. 17(1). 101–114. 217 indexed citations
16.
Kallio, Marko J., Mark L. McCleland, P. Todd Stukenberg, & Gary J. Gorbsky. (2002). Inhibition of Aurora B Kinase Blocks Chromosome Segregation, Overrides the Spindle Checkpoint, and Perturbs Microtubule Dynamics in Mitosis. Current Biology. 12(11). 900–905. 264 indexed citations
17.
Kallio, Marko J., John Eriksson, & Gary J. Gorbsky. (2000). Differences in Spindle Association of the Mitotic Checkpoint Protein Mad2 in Mammalian Spermatogenesis and Oogenesis. Developmental Biology. 225(1). 112–123. 43 indexed citations
18.
Holmberg, Carina I., Sara A. Illman, Marko J. Kallio, Andrey Mikhailov, & Lea Sistonen. (2000). Formation of nuclear HSF1 granules varies depending on stress stimuli. Cell Stress and Chaperones. 5(3). 219–219. 55 indexed citations
20.
Kallio, Marko J. & Jaana Lähdetie. (1995). Early G1 in the male rat meiotic cell cycle is hypersensitive to N-methyl-N-nitrosourea-induced micronucleus formation. Mutagenesis. 10(4). 279–285. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026